Clinical Trials
294 trialsSCOUT-1
AstraZeneca
BIOC
KU Leuven
PRSTEC_multipr
University Hospital Hradec Kralove
Quality of Life and Function of Patients With Pelvic Tumors After Undergoing Hemipelvectomy
M.D. Anderson Cancer Center
Genetic & Pathological Studies of BRCA1/BRCA2: Associated Tumors & Blood Samples
Stanford University
The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support
M.D. Anderson Cancer Center
CASCADE
University of Basel
Durvalumab With or Without Olaparib in Patients With Endometrial Cancers Regulatory Post Marketing Surveillance
AstraZeneca
Evaluation of DNA Methylation Markers for Endometrial Cancer Risk-stratification Using Patient-collected Urine and Vaginal Samples and Clinician-collected Cervical Samples From Women With Postmenopausal Bleeding
University of Aarhus
Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment
UNC Lineberger Comprehensive Cancer Center
DUOLife
AstraZeneca
Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
National Institutes of Health Clinical Center (CC)
LONGEVITI
University of Alberta
Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers
M.D. Anderson Cancer Center
iCaRe2
University of Nebraska
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
University of Wisconsin, Madison
REFLECT
University Health Network, Toronto
DP-04
AstraZeneca
BASECAMP-1
A2 Biotherapeutics Inc.
ENDOCancerDATA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
OLIVIA
AstraZeneca
REPLACE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
GYNECO-IMM&CO
Centre Leon Berard
CtDNA as a Novel Biomarker of Treatment Efficacy in Patients With Ovarian Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
PROBE-II
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
LYNX-EYE
San Raffaele University
CER
Cancer Support Community, Research and Training Institute, Philadelphia
SJFAMILY
St. Jude Children's Research Hospital
ENVISION
Exact Sciences Corporation
EPOCA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
ECHO
Mayo Clinic
Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study
University of Washington
DETECTR
University of British Columbia
A Bidirectional Cohort Study on Prophylactic Resection Surgery in Populations at Moderate-to-High Risk for Hereditary Ovarian Cancer
Peking University Third Hospital
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
National Institutes of Health Clinical Center (CC)
IGNITE-V
Hamilton Health Sciences Corporation
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
Mayo Clinic
The Registry of Genetic Alterations of Taiwan Ovarian Cancer
National Health Research Institutes, Taiwan
PROACTION:
PinkDx, Inc.
SENTRY
University of Utah
HPV-Vac-S
International Agency for Research on Cancer
Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity
Faculty of Medicine of Tunis
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Memorial Sloan Kettering Cancer Center
Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women
Ankara University
ASAP
Avera McKennan Hospital & University Health Center
(CLOCS-2)
Imperial College London
HART
General University Hospital, Prague
3D-PEDSURG
Assistance Publique - Hôpitaux de Paris
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
ELEPHAS-04
Mayo Clinic